Table 4

Best overall response

Best response*TN ≥65 y (n = 31)R/R (n = 101)R/R del(17p) (n = 34)All patients (N = 132)
ORR (CR+PR+PR-L)26 (84)91 (90)27 (79)117 (89)
 CR7 (23)7 (7)2 (6)14 (11)
 PR17 (55)81 (80)22 (65)98 (74)
 PR-L2 (6)3 (3)3 (9)5 (4)
SD3 (10)4 (4)4 (12)7 (5)
PD02 (2)1 (3)2 (2)
Missing2 (6)4 (4)2 (6)6 (5)
  • Values are n (%).

  • * By investigator assessment. NE, not evaluable; PD, progressive disease; SD, stable disease.